More to Drug Story 

Dale Brumfield's Back Page piece on Avastin (“Obama's Drug War,” Jan. 19) shows a strong political bias; after doing some research you will see a different perspective. Business Week's article on the subject stated: “Avastin was approved for breast cancer in February 2008 based on preliminary evidence suggesting it slowed disease progression. Two follow-up trials showed Avastin didn't prolong survival in women with breast cancer or improve symptoms, and the drug had a smaller effect on tumor growth than the Food and Drug Administration had expected. The agency decided the benefits didn't outweigh potential risks of serious bleeding, heart attacks and kidney damage.” I believe the FDA is supposed to determine the safety of food and drugs, so it appears it is just doing its job.
Kathy Kurtz


Subscribe to this thread:

Add a comment

Connect with Style Weekly

Newsletter Sign-Up

The Flash
The Bite
The Scoop

Most Popular Stories

  • OPINION: Failing the Test

    OPINION: Failing the Test

    If educators object to standardized testing, the answer is not to cheat but to find ways to teach the next generation about honesty.
    • Jul 10, 2018
  • OPINION: Et tu, Mayor Stoney?

    OPINION: Et tu, Mayor Stoney?

    Despite promises to be different, Mayor Stoney wants to reward Stone Brewing with a $20 million sweetheart deal that includes demolishing an historical structure.
    • Jul 3, 2018
  • Zero Tolerance, Zero Sense

    Zero Tolerance, Zero Sense

    Noncitizens have the same constitutional rights as anyone else to not have their children ripped away.
    • Jun 26, 2018
  • More »

Copyright © 2018 Style Weekly
Richmond's alternative for news, arts, culture and opinion
All rights reserved
Powered by Foundation